Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


GE Healthcare and Cellular Dynamics International Agree to Sublicense for Cellular Assay Patents 

 

 

December 18, 2012 - (CDI) - "GE Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE) and Cellular Dynamics International (CDI), a leading commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, announced today that GE Healthcare has licensed CDI to develop, manufacture and sell cellular assays and models derived from induced pluripotent stem (iPS) cells for use in drug discovery and toxicity screening." Read Full Article 

 

Posted on 20-Dec-12 by Toto, Brent
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: